Investment analysts at StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a note issued to investors on Thursday. The firm set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Price Performance
Shares of CO stock opened at $1.00 on Thursday. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50. The company has a market capitalization of $121.55 million, a P/E ratio of 1.56 and a beta of 0.16. The company’s 50-day simple moving average is $1.26 and its two-hundred day simple moving average is $1.39.
Global Cord Blood Company Profile
Featured Stories
- Five stocks we like better than Global Cord Blood
- Best Stocks Under $5.00
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- 3 Monster Growth Stocks to Buy Now
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- How to Calculate Options Profits
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.